Publications by authors named "Roger M Pinder"

Claim this Profile
N
Neuropsychiatric Disease and Treatment: 20 Years on.
Roger M Pinder

Neuropsychiatr Dis Treat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's choice: the best of 2011-2012.
Roger M Pinder

Neuropsychiatr Dis Treat· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New antidepressants or more of the same?
Roger M Pinder

Neuropsychiatr Dis Treat· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drugs for Parkinson’s disease: levodopa is still the gold standard.
Roger M Pinder

Neuropsychiatr Dis Treat· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin - From WMD to therapeutic agent and cosmetic aid.
Roger M Pinder

Neuropsychiatr Dis Treat· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.
Norman Sartorius, Thomas C Baghai, David S Baldwin, Barbara Barrett, Ursula Brand, Roger M Pinder

Int J Neuropsychopharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NDT goes Open Access.
Roger M Pinder, Allan Young

Neuropsychiatr Dis Treat· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of generalized anxiety disorder.
Roger M Pinder

Neuropsychiatr Dis Treat· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological gambling and dopamine agonists: A phenotype?
Roger M Pinder

Neuropsychiatr Dis Treat· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restless legs is a medical disorder and can be treated.
Roger M Pinder

Neuropsychiatr Dis Treat· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine - a suitable case for treatment?
Roger M Pinder

Neuropsychiatr Dis Treat· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why a new journal in the crowded area of neuroscience?
Roger M Pinder

Neuropsychiatr Dis Treat· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Roger M Pinder

Neuropsychiatr Dis Treat· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Roger M Pinder

Acta Neuropsychiatr· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of the principles of clinical drug development to a pharmacological challenge test of the serotonergic system.
Roger M Pinder

J Psychopharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chairmen's introduction.
Steven P Roose, Roger M Pinder

Eur Neuropsychopharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.
Martin M Katz, Uriel M Halbreich, Charles L Bowden, Alan Frazer, Roger M Pinder

Neuropsychopharmacology· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
Stuart A Montgomery, Per Bech, Pierre Blier, Hans-Jürgen Möller, Andrew A Nierenberg, Roger M Pinder

J Clin Psychiatry· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the feasibility of designing new antidepressants.
Roger M Pinder

Hum Psychopharmacol· January 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis